OR2T11

Chr 1

olfactory receptor family 2 subfamily T member 11

Also known as: OR2T11Q

OR2T11 encodes an olfactory receptor that interacts with odorant molecules to initiate neuronal responses triggering smell perception through G-protein-coupled receptor signaling. This gene is a segregating pseudogene where some individuals carry functional alleles while others have non-functional variants, but no specific diseases have been established from OR2T11 mutations. The gene shows very low constraint against loss-of-function variants, consistent with its variable functionality across populations.

ResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.94
Clinical SummaryOR2T11
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
69 unique Pathogenic / Likely Pathogenic· 70 VUS of 149 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.94LOEUF
pLI 0.000
Z-score -1.14
OE 1.54 (0.841.94)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.44Z-score
OE missense 1.09 (0.971.23)
195 obs / 178.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.54 (0.841.94)
00.351.4
Missense OE1.09 (0.971.23)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 8 / 5.2Missense obs/exp: 195 / 178.6Syn Z: -0.36
DN
0.84top 10%
GOF
0.84top 5%
LOF
0.1895th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

149 submitted variants in ClinVar

Classification Summary

Pathogenic63
Likely Pathogenic6
VUS70
Likely Benign5
Benign5
63
Pathogenic
6
Likely Pathogenic
70
VUS
5
Likely Benign
5
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
63
0
63
Likely Pathogenic
0
0
6
0
6
VUS
0
60
10
0
70
Likely Benign
1
3
1
0
5
Benign
1
0
4
0
5
Total263840149

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

OR2T11 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 3 results · since 2015Search PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC